Original Research

Published on 15 May 2024

Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis

in Neurodegeneration

Jiajia Fu
Xiaohui Lai
Qianqian Wei
Xueping Chen
Huifang Shang

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1375892

1,381 views
1 citation

Original Research

Published on 10 May 2024

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease

in Neurodegeneration

Yaqiong Xiao
Lei Gao
Yubin Hu
The Alzheimer’s Disease Neuroimaging Initiative

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1366761

1,194 views

Original Research

Published on 09 May 2024

Differentiation of hemispheric white matter lesions in migraine and multiple sclerosis with similar radiological features using advanced MRI

in Neurodegeneration

Flóra John
Gréta Kis-Jakab
Hedvig Komáromy
Gábor Perlaki
Gergely Orsi
Edit Bosnyák
Renáta Rozgonyi
Anita Trauninger
Kata Eklics
David Olayinka Kamson

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1384073

2,289 views

Original Research

Published on 09 May 2024

Association between serum potassium and Parkinson’s disease in the US (NHANES 2005–2020)

in Neurodegeneration

Xue Zhou
Jingtong Zhao
Yang Liu
Xiaozhou Sun
Xuefeng Li
Jixiang Ren
Qingjie Li
Dong Han
Ting Pan
Yingqi Shi

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1387266

3,466 views

Review

Published on 06 May 2024

Chlamydia pneumoniae in Alzheimer's disease pathology

in Neurodegeneration

Lalita Subedi
Bhakta Prasad Gaire
Yosef Koronyo
Maya Koronyo-Hamaoui
Timothy R. Crother

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1393293

2,331 views

Original Research

Published on 03 May 2024

EFhd2 co-aggregates with monomeric and filamentous tau in vitro

in Neurodegeneration

Ahlam S. Soliman
Andrew Umstead
Jared Lamp
Irving E. Vega

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1373410

987 views

Original Research

Published on 03 May 2024

Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson’s disease

in Neurodegeneration

Guolin Shi
Tingting Wu
Xuetao Li
Debin Zhao
Qiuyuan Yin
Lei Zhu

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1385675

2,109 views

Original Research

Published on 30 Apr 2024

Effect of emotional stimulus on response inhibition in people with mild cognitive impairment: an event-related potential study

in Neurodegeneration

Jing Wang
Cheng Li
Xiaohong Yu
Yue Zhao
Enfang Shan
Ying Xing
Xianwen Li

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1357435

1,141 views
1 citation

Editorial

Published on 30 Apr 2024

Editorial: New insights into atypical Alzheimer's disease: from clinical phenotype to biomarkers

in Neurodegeneration

Neha Atulkumar Singh
Irene Sintini

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1414443

1,009 views
1 citation

Review

Published on 30 Apr 2024

Defining the concept of reserve in the motor domain: a systematic review

in Neurodegeneration

Andreina Giustiniani
Angelo Quartarone

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1403065

1,199 views
1 citation

Mini Review

Published on 26 Apr 2024

Therapeutic developments for neurodegenerative GM1 gangliosidosis

in Neurodegeneration

Dorian Foster
Lucian Williams
Noah Arnold
Jessica Larsen

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1392683

2,495 views
3 citations

Editorial

Published on 25 Apr 2024

Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting

in Neurodegeneration

Alessandra Bigi
Ryan Limbocker
Cristina Cecchi

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1415641

876 views

Brief Research Report

Published on 24 Apr 2024

EBV and multiple sclerosis: expression of LMP2A in MS patients

in Neurodegeneration

Simone Agostini
Roberta Mancuso
Domenico Caputo
Marco Rovaris
Mario Clerici

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1385233

1,604 views

Opinion

Published on 22 Apr 2024

Potential roles of gangliosides in chemical-induced neurodegenerative diseases and mental health disorders

in Neurodegeneration

Yutaka Itokazu
Alvin V. Terry

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1391413

963 views

Original Research

Published on 12 Apr 2024

Retinal atrophy, inflammation, phagocytic and metabolic disruptions develop in the MerTK-cleavage-resistant mouse model

in Neurodegeneration

Julie Enderlin
Quentin Rieu
Salomé Réty
Elora M. Vanoni
Solène Roux
Julie Dégardin
Quénol César
Sébastien Augustin
Caroline Nous
Bishuang Cai

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1256522

1,859 views
1 citation

Original Research

Published on 09 Apr 2024

Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum

in Neurodegeneration

Rosaleena Mohanty
Daniel Ferreira
Eric Westman

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1355695

1,407 views
1 citation

Navigation group

Articles

Associations of cerebrospinal fluid profiles with severity and mortality risk of amyotrophic lateral sclerosis

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease

Differentiation of hemispheric white matter lesions in migraine and multiple sclerosis with similar radiological features using advanced MRI

Association between serum potassium and Parkinson’s disease in the US (NHANES 2005–2020)

Chlamydia pneumoniae in Alzheimer's disease pathology

EFhd2 co-aggregates with monomeric and filamentous tau in vitro

Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson’s disease

Effect of emotional stimulus on response inhibition in people with mild cognitive impairment: an event-related potential study

Editorial: New insights into atypical Alzheimer's disease: from clinical phenotype to biomarkers

Defining the concept of reserve in the motor domain: a systematic review

Therapeutic developments for neurodegenerative GM1 gangliosidosis

Editorial: Promising therapeutic strategies for Alzheimer's disease: a focus on amyloid-β targeting

EBV and multiple sclerosis: expression of LMP2A in MS patients

Potential roles of gangliosides in chemical-induced neurodegenerative diseases and mental health disorders

Retinal atrophy, inflammation, phagocytic and metabolic disruptions develop in the MerTK-cleavage-resistant mouse model

Multi-pathological contributions toward atrophy patterns in the Alzheimer’s disease continuum